Lotus Pharm vs Bioptik Technology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Bioptik Technology (4161) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Bioptik Technology

0%+226%-41%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYBioptik TechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$48.1 million-20.3%
Sep 2026NT$2.77 billion+128.0%NT$47.7 million-41.1%
Aug 2026NT$2.11 billion+81.7%NT$50.9 million-23.6%
Jul 2026NT$2.49 billion+3.9%NT$95.5 million+41.3%
Jun 2026NT$3.4 billion+225.5%NT$77.1 million-1.3%
May 2026NT$2.32 billion+105.8%NT$96 million+73.8%
Apr 2026NT$3.09 billion+19.9%NT$64.5 million+12.8%
Mar 2026NT$4.35 billion+173.6%NT$95.1 million+40.5%
Feb 2026NT$2.24 billion+131.5%NT$54.6 million-26.6%
Jan 2026NT$2.05 billion-5.5%NT$74.6 million+39.1%
Dec 2025NT$2.44 billion+66.9%NT$74.4 million-7.3%
Nov 2025NT$1.06 billion-0.2%NT$101 million+17.9%
Oct 2025NT$2.75 billion+46.0%NT$60.4 million-2.4%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16